英国一公司推出在HIV患者中检测结核的新方法

 
近期一项研究证实：一种新型检测方法能够在免疫系统严重受到抑制的HIV患者中检测结核。

Oxford Immunotec(Abingdon, UK)宣布了这项研究，这项研究在Chelsea和Westminster医院(London, UK)中进行的，显示该公司T-Spot结核检测能够在HIV患者中检测TB，即使在他们的CD4 T细胞计数小于200/µl的时候。该研究还证实了T-Spot结核检测能够作为HIV患者结核德排除检测。这些结果在2006年3月Brighton (UK)英国HIV学会年度会议上进行了报道。

Test Detects TB in HIV Patients
 
A recent study has confirmed that a new test is able to detect tuberculosis (TB) in HIV patients whose immune systems are severely compromised.

Oxford Immunotec (Abingdon, UK) announced that the study, which was performed at the Chelsea and Westminster hospital (London, UK), showed that the company’s T-Spot.TB test is able to detect TB in HIV patients, even when their CD4 T cell count is less than 200 cells/µl. The study also confirmed the ability of the T-Spot.TB to be used as a “rule-out” test for TB in HIV patients. The results of the study were presented at the annual meeting of the British HIV Association in Brighton (UK) in March 2006.